Weill Cornell Medicine researchers have determined the full-length structure and function of a blood pressure-regulating hormone receptor, which may enable better drug targeting of the receptor for diseases such as hypertension and heart failure.
The new “How NYC Moves” report, co-authored by a Cornell Tech expert and New York City’s Mayor’s Office, offers strategies to leverage technology to speed transportation analyses and unlock housing development.
A new analysis finds that Cornell Tech, its alumni and startups achieved $768 million in total economic impact in New York City in the 2023-24 fiscal year. That impact is expected to reach $1.5 billion by 2030.
It’s no secret that coordination between marketing and sales is an important component of generating revenue for businesses – unfortunately the reality isn’t quite so harmonious. Businesses invest countless hours and thousands of…
The process of identifying promising small molecule drug candidates that target cancer checkpoints may become faster and smarter through virtual screening, according to Weill Cornell Medicine researchers.
Weill Cornell Medicine researchers have received a five-year, $6.2 million grant from the National Institute on Aging, part of the National Institutes of Health, to build a portable, high-resolution Positron Emission Tomography scanner that can detect the earliest stages of Alzheimer’s disease.
Cornell researchers have found that in social VR settings, the decision to disclose an invisible disability – a physical, mental or neurological condition that’s not apparent but can limit a person’s movements, senses or activities – is personal.
Dr. Chani Traube, professor of pediatrics at Weill Cornell Medicine, has been awarded a $3.4 million grant from the National Institutes of Health for a clinical trial called Optimizing Pain Treatment in Children on Mechanical ventilation.
